Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 3Withdrawn 1Terminated 1

Sponsor Class

OTHER 5NETWORK 1INDUSTRY 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Genitourinary 5Thoracic 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Leukemia, Lymphocytic, Chronic, B-Cell 21Congenital Abnormalities 21Leukemia 20Lymphoma, Follicular 19Lymphoma, B-Cell, Marginal Zone 19Breast Neoplasms 19Multiple Myeloma 17Lymphoma, Mantle-Cell 17Myelodysplastic Syndromes 15Lymphoma, Non-Hodgkin 15Lymphoma, Large B-Cell, Diffuse 15Myeloproliferative Disorders 13Lymphoma, Large-Cell, Immunoblastic 13Lymphoma 13Burkitt Lymphoma 13Blast Crisis 13Lymphoma, T-Cell, Cutaneous 12Leukemia, Myelomonocytic, Chronic 12Leukemia, Myeloid, Accelerated Phase 12Sezary Syndrome 11Mycosis Fungoides 11Leukemia, Myeloid, Chronic-Phase 11Neoplasms, Plasma Cell 10Hodgkin Disease 10Waldenstrom Macroglobulinemia 9Primary Myelofibrosis 9Pdgfra-Associated Chronic Eosinophilic Leukemia 8Leukemia, Neutrophilic, Chronic 8

Interventions

Sunitinib 26Everolimus 20Bevacizumab 19aldesleukin 18Sorafenib 16Nivolumab 16Interleukin-2 14pembrolizumab 13Peripheral Blood Stem Cell Transplantation 13fludarabine phosphate 12Radiotherapy 12Interferon-alpha 12Cyclophosphamide 12Radiosurgery 11Filgrastim 11Blood Specimen Collection 11Ipilimumab 10Gemcitabine 10Axitinib 9Surveys and Questionnaires 7Gene Expression Profiling 7Cryosurgery 7temsirolimus 6pazopanib 6Surgical Procedures, Operative 6durvalumab 5cabozantinib 5atezolizumab 5Mycophenolic Acid 5Immunohistochemistry 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Kidney Neoplasms × Flow Cytometry × Clear all
NCT00617799 2023-10-10

Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma

University of Nebraska

Completed
15 enrolled
DermatologicGenitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Melanoma

NCT00489710 2023-08-22

Talabostat in Treating Patients With Metastatic Kidney Cancer

University of Nebraska

Phase 2 Withdrawn
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00514215 2020-03-05

Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer

Barbara Ann Karmanos Cancer Institute

Phase 2 Completed
8 enrolled 5 charts
GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Neoplasm Metastasis

NCT02450448 2015-12-30

The Detection of Circulating Tumor Cells (CTCs) in Patients With Renal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

Fuda Cancer Hospital, Guangzhou

Completed
60 enrolled
Genitourinary

Kidney Neoplasms, Neoplastic Cells, Circulating

NCT00589550 2015-06-08

PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer

Ohio State University Comprehensive Cancer Center

Phase 1 Terminated
1 enrolled 2 charts
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡